14 Aug CABASER 1 MG TABLETS, CABERGOLINE 1 MG TABLETS patient leaflet, side effects, dosage

CABASER 1 MG TABLETS, CABERGOLINE 1 MG TABLETS patient leaflet, side effects, dosage

The main metabolite identified in urine is Steroid Injections buy in USA 6-allyl-8b-carboxy-ergoline (4-6% of dose). Three other metabolites were identified urine (less than 3% of dose). These might include nausea, vomiting, gastric complaints, hypotension, nasal congestion, confusion hallucinations, psychosis or thought/perception disturbances.

Side Effects for Dostinex

Always take this medicine exactly as your doctor or pharmacist has told you. Cabaser can cause drowsiness (somnolence) and sudden sleepy episodes, in some cases without any warning signs or awareness. It is used after your doctor has tried other treatments that have not worked or for people who are already taking other medicines for this illness to help control other symptoms.

• The human elimination half-life is estimated to be 63 to 68 hours in patients with Parkinson’s disease and 79 to 115 hours in patients with pituitary tumors.
• In studies where the pharmacokinetic interactions of cabergoline with L-dopa or selegiline were evaluated, no interactions were observed.
• This is usually by adding half-one tablet to the daily dose once every week.
• Erythrocyte sedimentation rate (ESR) has been found to be abnormally increased in association with pleural effusion/fibrosis.
• Your doctor may then increase the dose until he finds a suitable dose to control your symptoms.

Schedule of Cabaser

It can be used to treat certain menstrual problems, fertility problems in men and women, and pituitary prolactinomas (tumors of the pituitary gland). Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed. You may have increased sexual urges, unusual urges to gamble, or other intense urges while taking cabergoline. Preclinical safety studies of cabergoline indicate a consistent safety margin for this compound in rodents and in monkeys, as well as a lack of teratogenic, genotoxic or carcinogenic potential. Additional appropriate investigations such as erythrocyte sedimentation rate, and serum creatinine measurements should be performed if necessary to support a diagnosis of a fibrotic disorder.

Overdosage might be expected to produce nasal congestion, syncope, or hallucinations. Measures to support blood pressure should be taken ifnecessary. The mutagenic potential of cabergoline was evaluated andfound to be negative in a battery of in vitro tests.

[Major] The use of cabergoline is contraindicated in patients with uncontrolled hypertension. You should not breast-feed while taking this medicine as this medicine may affect milk production (lactation). If you need to take Cabergoline you should use another method of feeding yourbaby. The tablets are packed in white plastic bottles with a plastic tamper evident, child resistant screw cap incorporating a silica gel desiccant which absorbs moisture. Do not throw away any medicines via wastewater or household waste.

How to take cabergoline

Ask your healthcare professional how you should dispose of any medicine you do not use. If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.

This leaflet provides important information about using Cabaser. You should also speak to your doctor or pharmacist if you would like further information or if you have any concerns or questions about using Cabaser. Do not take if you have an allergy to any medicine containing cabergoline, any other ergot alkaloid or any of the ingredients listed.